Synergistic anti-tumor effects of liraglutide with metformin on pancreatic cancer cells.
Either metformin or liraglutide has been reported to have anti-tumor effects on pancreatic cancer cells. However, it is not clear whether their combined treatment has additive or synergistic anti-tumor effects on pancreatic cancer cells. In this study, the human pancreatic cancer cell line MiaPaca-2...
Main Authors: | Ran Lu, Jin Yang, Rui Wei, Jing Ke, Qing Tian, Fei Yu, Junling Liu, Jingjing Zhang, Tianpei Hong |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5999272?pdf=render |
Similar Items
-
Comparative evaluation of metformin and liraglutide cardioprotective effect in rats with impaired glucose tolerance
by: Anna Simanenkova, et al.
Published: (2021-03-01) -
Remission of Bulimia Nervosa Observed During Administration of Liraglutide and Metformin: A Case Report
by: Margarita Perez-Cheron, MD, FACE
Published: (2018-05-01) -
Acute Pancreatitis Associated with Exenatide and Liraglutide: a Meta-Analysis
by: Carlos Alves, et al.
Published: (2012-07-01) -
Synergistic metalloproteinase-based remodeling of matrix by pancreatic tumor and stromal cells.
by: Hong Cao, et al.
Published: (2021-01-01) -
Effects of liraglutide combined with metformin on lipid metabolism and micro-inflammatory response in T2DM patients with obesity
by: Wei-Huan Zhang, et al.
Published: (2018-08-01)